New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Waters Corporation
WAT
Shape
US Flag

NYSE

21B

Medical - Diagnostics & Research

Next Earning date - 01 Nov 2024

21B

Medical - Diagnostics & Research

Next Earning date - 01 Nov 2024

357.97USD
Shape5.33 ( 1.51%)
favorite-chart

Relative Strenght

61
favorite-chart

Volume Buzz

-42%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

3%

Quote Panel

Shape
Updated October 12, 2024
1W 2.30 % 1M 9.85 % 3M 18.17 % 1Y 41.71 %

Key Metrics

Shape
  • Market Cap

    21.25B


  • Shares Outstanding

    59.36M


  • Share in Float

    59.22M


  • Dividende

    0


  • Earning Date

    01 Nov 2024


  • Price Target

    357.97


  • Average Volume

    377409


  • Beta

    0.956


  • Range

    231.9-367.21


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.waters.com


  • Sector

    Healthcare


Fundamentals

Shape

31.68x

P/E Ratio

7.39x

P/S Ratio

15.04x

P/B Ratio

1.4

Debt/Equity

20.7%

Net Margin

$10.0

EPS

How WAT compares to sector?

P/E Ratio

Relative Strength

Shape

WAT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$3B

Shape335%

2025-Revenue

$11.86

Shape392%

2025-EPS

$1B

Shape340%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Jefferies

upgrade

Previous: Not converted

2024-10-08

Now: Buy

Wells Fargo

initialise

Previous: Not converted

2024-08-27

Now: Overweight

Leerink Partners

upgrade

Previous: Not converted

2024-08-01

Now: Outperform

Barclays

downgrade

Previous: Not converted

2023-11-13

Now: Underweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-28%

2.64
vs 3.67

Q4.22

arrow
arrow

+5%

3.84
vs 3.67

Q2.23

arrow
arrow

-11%

2.49
vs 2.8

Q3.23

arrow
arrow

+2%

2.8
vs 2.75

Q3.23

arrow
arrow

+3%

2.84
vs 2.75

Q4.23

arrow
arrow

-6%

3.62
vs 3.84

Q1.24

arrow
arrow

N/A

2.21
vs NA

Q2.24

arrow
arrow

+6%

2.63
vs 2.49

Q3.24

arrow
arrow

-6%

2.68
vs 2.84

Q4.24

arrow
arrow

+13%

4.1
vs 3.62

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-15%

708.6M  vs 836.4M

Q4.22

arrow
arrow

+3%

858.5M  vs 836.4M

Q2.23

arrow
arrow

-1%

684.7M  vs 690.6M

Q3.23

arrow
arrow

+4%

740.6M  vs 714.3M

Q3.23

arrow
arrow

0%

711.7M  vs 714.3M

Q4.23

arrow
arrow

-5%

819.5M  vs 858.5M

Q1.24

arrow
arrow

NA

636.8M  vs NA

Q2.24

arrow
arrow

+3%

708.5M  vs 684.7M

Q3.24

arrow
arrow

+0%

713M  vs 711.7M

Q4.24

arrow
arrow

+4%

854.3M  vs 819.5M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+40%

0.4
vs 0.42

Q4.22

arrow
arrow

+45%

0.45
vs 0.4

Q2.23

arrow
arrow

+23%

0.23
vs 0.45

Q3.23

arrow
arrow

+20%

0.2
vs 0.23

Q3.23

arrow
arrow

+15%

0.15
vs 0.2

Q4.23

arrow
arrow

+19%

0.19
vs 0.15

Q1.24

arrow
arrow

+8%

0.08
vs 0.19

Q2.24

arrow
arrow

+10%

0.1
vs 0.08

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

644

644
vs 654

-2%

Q4.22

arrow
arrow

659

659
vs 644

2%

Q1.23

arrow
arrow

682

682
vs 659

3%

Q2.23

arrow
arrow

655

655
vs 682

-4%

Q3.23

arrow
arrow

662

662
vs 655

1%

Q4.23

arrow
arrow

687

687
vs 662

4%

Q1.24

arrow
arrow

699

699
vs 687

2%

Q2.24

arrow
arrow

686

686
vs 699

-2%

Earnings Growth

Latest News